Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab-IRDye800 for Detecting Lung Cancer During Surgery
NCT03582124Phase 2Recruiting
- Sponsor
- Stanford University
- Start
- Jul 2018
- Primary completion
- Apr 2027
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in lung cancer, sponsored by Stanford University. Started Jul 2018; status: recruiting.
02
Drugs
panitumumab
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT03582124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03582124.